Makoto Okabe
Director/Board Member at NORITAKE CO., LIMITED
Makoto Okabe active positions
| Companies | Position | Start | End |
|---|---|---|---|
| NORITAKE CO., LIMITED | Director/Board Member | 22/06/2023 | - |
| Corporate Officer/Principal | 22/06/2023 | - |
Career history of Makoto Okabe
Former positions of Makoto Okabe
| Companies | Position | Start | End |
|---|---|---|---|
ImmunoFrontier, Inc.
 ImmunoFrontier, Inc. Miscellaneous Commercial ServicesCommercial Services ImmunoFrontier, Inc. is a holding company that specializes in the research and development of cancer vaccines. It develops CHP cancer protein vaccines and multifunctional cancer DNA vaccines. The firm also establishes technology solutions for promoting the creation of cancer DNA vaccines and therapeutics for immune diseases. The company was founded by Shiku Hiroshi on October 5, 2004 and is headquartered in Tokyo, Japan. | Director/Board Member | 21/07/2011 | - |
Statistics
International
| Japan | 3 |
Operational
| Director/Board Member | 2 |
| Corporate Officer/Principal | 1 |
Sectoral
| Commercial Services | 2 |
| Producer Manufacturing | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| NORITAKE CO., LIMITED | Producer Manufacturing |
| Private companies | 1 |
|---|---|
ImmunoFrontier, Inc.
ImmunoFrontier, Inc. Miscellaneous Commercial ServicesCommercial Services ImmunoFrontier, Inc. is a holding company that specializes in the research and development of cancer vaccines. It develops CHP cancer protein vaccines and multifunctional cancer DNA vaccines. The firm also establishes technology solutions for promoting the creation of cancer DNA vaccines and therapeutics for immune diseases. The company was founded by Shiku Hiroshi on October 5, 2004 and is headquartered in Tokyo, Japan. | Commercial Services |
- Stock Market
- Insiders
- Makoto Okabe
- Experience